Published in Blood on August 01, 1996
Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci U S A (1998) 1.08
Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state. Leuk Lymphoma (2011) 0.86
Assessment of three generations of mice derived by ICSI using freeze-dried sperm. Zygote (2009) 0.81
Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas. Mol Pathol (1998) 0.78
Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia. Br J Cancer (2005) 0.75
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol (2004) 3.29
Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia. Lancet (1994) 3.24
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol (2006) 2.72
Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med (1993) 2.52
Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ (2001) 2.40
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood (1994) 2.24
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant (2009) 2.00
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 1.97
Prognostic factors in metastatic breast cancer. Cancer Clin Trials (1981) 1.96
The EBMT activity survey: 1990-2010. Bone Marrow Transplant (2012) 1.96
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med (1997) 1.93
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant (2011) 1.65
Historical demography of Mullerian mimicry in the neotropical Heliconius butterflies. Proc Natl Acad Sci U S A (2004) 1.65
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med (1999) 1.59
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. Semin Hematol (2000) 1.59
The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer (2005) 1.54
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? J Clin Oncol (1999) 1.47
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant (2007) 1.47
Preterm birth and the availability of cord blood for HPC transplantation. Transfusion (2000) 1.47
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant (2002) 1.46
Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia. EMBO J (2000) 1.44
Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol Cell Biol (2001) 1.41
t(8;9)(p11;q32) in atypical chronic myeloid leukaemia: a new cytogenetic-clinicopathologic association? Br J Haematol (1992) 1.39
Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood (1992) 1.36
Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol (2000) 1.32
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant (2012) 1.28
Analysis of somatic mutations at human minisatellite loci in tumors and cell lines. Genomics (1989) 1.28
Late clonal diseases of treated aplastic anemia. Semin Hematol (2000) 1.27
Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol Cell Biol (1988) 1.27
Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest (1995) 1.25
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood (1999) 1.19
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant (2012) 1.18
Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation. Ann Hematol (1998) 1.15
Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood (1996) 1.14
The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol (2006) 1.11
Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br J Rheumatol (1994) 1.10
A pilot iron substitution programme in female blood donors with iron deficiency without anaemia. Vox Sang (2010) 1.10
Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients. Am J Clin Pathol (1992) 1.10
Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A). Cell Death Differ (2007) 1.09
Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. Biochem J (1995) 1.09
Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant (2005) 1.08
Assessment of clonality in human tumors: a review. Cancer Res (1990) 1.08
The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet (2001) 1.08
MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene (2012) 1.08
Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest (1987) 1.07
Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene (2006) 1.06
Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia. Leukemia (2010) 1.05
Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation. Bone Marrow Transplant (1997) 1.04
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. J Clin Oncol (1997) 1.04
Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant (2008) 1.03
Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood (1997) 1.03
Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood (1995) 1.02
Hybrid incompatibility is consistent with a hybrid origin of Heliconius heurippa Hewitson from its close relatives, Heliconius cydno Doubleday and Heliconius melpomene Linnaeus. J Evol Biol (2005) 1.01
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplant (2006) 1.01
Non-endocrine late complications in children after allogeneic haematopoietic SCT. Bone Marrow Transplant (2008) 1.00
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene (1998) 0.99
Induction of Bim limits cytokine-mediated prolonged survival of neutrophils. Cell Death Differ (2009) 0.99
FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood (1998) 0.99
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant (2007) 0.98
Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis. Bone Marrow Transplant (2004) 0.98
cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif. Nucleic Acids Res (1993) 0.98
Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukemia. Cancer Genet Cytogenet (1999) 0.98
Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol (1993) 0.98
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant (2005) 0.98
Anemia: an indicator for malnutrition in the elderly. Ann Hematol (2001) 0.97
A myeloperoxidase cDNA clone identifies an EcoRV RFLP. Nucleic Acids Res (1990) 0.97
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant (2006) 0.96
[Stenosing ganglioneuromatosis of the small intestine with ileus and ileal rupture]. Schweiz Med Wochenschr (1981) 0.95
Prognostic impact of iron parameters in patients undergoing allo-SCT. Bone Marrow Transplant (2011) 0.94
Id2 expression increases with differentiation of human myeloid cells. Blood (1996) 0.93
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 0.93
Radioreceptor assay for alpha-MSH using mouse B16 melanoma cells+. J Recept Res (1988) 0.93
Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy. Leukemia (2012) 0.93
Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 0.93
DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function. Oncogene (2008) 0.93
PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity. Oncogene (2008) 0.93
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis. Cancer Res (1999) 0.92
Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia. Biochem Biophys Res Commun (2000) 0.92
RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood (1995) 0.91